03-07-2025
Spineway : GMED approval for new production line dedicated to ESP prostheses - First production of LP-ESP intervertebral disc prostheses
Press release
Ecully, July 3, 2025 – 6:30
GMED approval for new production line dedicated to ESP prostheses
First production of LP-ESP intervertebral disc prostheses
Spineway, a specialist in innovative implants for the treatment of severe spine disorders, announces that its subsidiary Spine Innovations has received GMED (French notified body) approval for its new production line dedicated to its LP-ESP and CP-ESP intervertebral disc prostheses. This approval is a significant strategic milestone for the Group, ensuring the manufacturing and supply of its innovative ESP prostheses.
Located in La Rochelle, on the premises of a long-standing Spineway partner, the new line includes a clean room for injection operations.
In line with the schedule1, the first LP-ESP prostheses went into production last month and the first implants from this new line should be available by the end of July.
'The approval of this new production line allows us to secure our supply chain while doubling our production capacity. It also reflects our industrial commitment in France and our desire to continue integrating the manufacture of spinal implants,' said Stéphane Leroux, CEO of Spineway.
Find out all about Spineway at
This press release has been prepared in both English and French. In case of discrepancies, the French version shall
Available Tuesday through Thursday
Solène Kennisspineway@ Press release of March 24, 2025
Attachment
CP_SPW_Ligne_ESP_VDEF_EN
